山莨菪碱凝胶防治输注康莱特所致静脉炎的临床研究  被引量:4

Clinical research in prevention and cure effect of anlsodamine gel on phlebitis caused by intravenous infusion of KLT

在线阅读下载全文

作  者:王华[1] 李德明[1] 范义凤[1] 

机构地区:[1]南通大学附属医院,226001

出  处:《中国实用护理杂志(中旬版)》2010年第7期9-11,共3页Chinese Journal of Practical Nursing

基  金:2004年南通市第二批社会发展计划项目(18)

摘  要:目的探讨山莨菪碱凝胶涂搽防治输注康莱特所致静脉炎的效果。方法将96例静脉输注康莱特的患者随机分为实验组和对照组各48例。实验组患者在静脉输注康莱特前3-5min将2%山莨菪碱凝胶沿静脉走向均匀地涂搽于输液穿刺点上方的皮肤上;对照组先不做任何处理,观察其静脉炎的情况后再对有阳性反应的患者用2%山莨菪碱凝胶涂搽于输液穿刺点上方的皮肤上。比较2组静脉炎的发生率、发生程度及治疗效果。结果对照组静脉炎的发生率为68.7%,其中Ⅱ、Ⅲ级占60.4%;实验组静脉炎的发生率为10.4%,且未发生Ⅱ、Ⅲ级静脉炎。对照组33例患者及实验组5例患者经过治疗后静脉炎症状全部消失,实验组和对照组静脉炎的发生率比较差异显著。结论2%山莨菪碱凝胶涂搽能有效防治输注康莱特所致静脉炎的发生。Objective To investigate the prevention and cure effect of anisodamine gel on phlebitis caused by intravenous infusion of KLT. Methods 96 patients with intravenous infusion of KLT were di- vided into the experimental group and the control group, 48 patients in each group, and the skin at the top of transfusion puncture points of the patients of the experimental group was evenly embrocated with 2% anisodamine gel along the vein before 3 to 5 minutes of intravenous infusion of KLT,while the control group was without any treatment. After observing the situation of venous injury, the skin at the top of transfusion puncture points of the positive patients would be embrocated with 2% anisodamine gel. The incidence, de- gree of phlebitis and treatment effect were compared between the two groups. Results The incidence rate of phlebitis of the control group was 68.7%, of which grade II, III occupied 60.4%, while the incidence rate of phlebitis of the experimental group was 10.4%, in which there was no occurrence of grade II, III phlebitis. All the venous injury symptoms of 33 patients of the control group and 5 patients of the experi- mental group disappeared after treatment, and after statistical processing, the incidence rate of phlebitis in the experimental group and the control group Showed significant differences. Conclusions The embro- eating of 2% anisodamine gel can effectively avoid the occurrence of the phlebitis caused by intravenous infusion of KLT.

关 键 词:山莨菪碱凝胶 康莱特 静脉炎 

分 类 号:R971.92[医药卫生—药品]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象